178 related articles for article (PubMed ID: 26432439)
1. Inhibition of osteoclastogenesis through siRNA delivery with tunable mesoporous bioactive nanocarriers.
Kim TH; Singh RK; Kang MS; Kim JH; Kim HW
Acta Biomater; 2016 Jan; 29():352-364. PubMed ID: 26432439
[TBL] [Abstract][Full Text] [Related]
2. Intracellular co-delivery of Sr ion and phenamil drug through mesoporous bioglass nanocarriers synergizes BMP signaling and tissue mineralization.
Lee JH; Mandakhbayar N; El-Fiqi A; Kim HW
Acta Biomater; 2017 Sep; 60():93-108. PubMed ID: 28713017
[TBL] [Abstract][Full Text] [Related]
3. Licorice isoliquiritigenin-encapsulated mesoporous silica nanoparticles for osteoclast inhibition and bone loss prevention.
Sun X; Zhang J; Wang Z; Liu B; Zhu S; Zhu L; Peng B
Theranostics; 2019; 9(18):5183-5199. PubMed ID: 31410209
[TBL] [Abstract][Full Text] [Related]
4. Capacity of mesoporous bioactive glass nanoparticles to deliver therapeutic molecules.
El-Fiqi A; Kim TH; Kim M; Eltohamy M; Won JE; Lee EJ; Kim HW
Nanoscale; 2012 Dec; 4(23):7475-88. PubMed ID: 23100043
[TBL] [Abstract][Full Text] [Related]
5. Proliferation, differentiation and gene expression of osteoblasts in boron-containing associated with dexamethasone deliver from mesoporous bioactive glass scaffolds.
Wu C; Miron R; Sculean A; Kaskel S; Doert T; Schulze R; Zhang Y
Biomaterials; 2011 Oct; 32(29):7068-78. PubMed ID: 21704367
[TBL] [Abstract][Full Text] [Related]
6. Dual actions of osteoclastic-inhibition and osteogenic-stimulation through strontium-releasing bioactive nanoscale cement imply biomaterial-enabled osteoporosis therapy.
Lee NH; Kang MS; Kim TH; Yoon DS; Mandakhbayar N; Jo SB; Kim HS; Knowles JC; Lee JH; Kim HW
Biomaterials; 2021 Sep; 276():121025. PubMed ID: 34298444
[TBL] [Abstract][Full Text] [Related]
7. Protein phosphatase 2A as a new target for downregulating osteoclastogenesis and alleviating titanium particle-induced bone resorption.
Wang L; Guo X; Zhou W; Ding Y; Shi J; Wu X; Liu Y; Xu Y; Yang H; Geng D
Acta Biomater; 2018 Jun; 73():488-499. PubMed ID: 29656074
[TBL] [Abstract][Full Text] [Related]
8. The large zinc finger protein ZAS3 is a critical modulator of osteoclastogenesis.
Liu S; Madiai F; Hackshaw KV; Allen CE; Carl J; Huschart E; Karanfilov C; Litsky A; Hickey CJ; Marcucci G; Huja S; Agarwal S; Yu J; Caligiuri MA; Wu LC
PLoS One; 2011 Mar; 6(3):e17161. PubMed ID: 21390242
[TBL] [Abstract][Full Text] [Related]
9. PSTP-3,5-Me Inhibits Osteoclast Differentiation and Bone Resorption.
Cho E; Chen Z; Lee J; Lee S; Lee TH
Molecules; 2019 Sep; 24(18):. PubMed ID: 31540026
[TBL] [Abstract][Full Text] [Related]
10. Gene delivery nanocarriers of bioactive glass with unique potential to load BMP2 plasmid DNA and to internalize into mesenchymal stem cells for osteogenesis and bone regeneration.
Kim TH; Singh RK; Kang MS; Kim JH; Kim HW
Nanoscale; 2016 Apr; 8(15):8300-11. PubMed ID: 27035682
[TBL] [Abstract][Full Text] [Related]
11. Delivery of dimethyloxallyl glycine in mesoporous bioactive glass scaffolds to improve angiogenesis and osteogenesis of human bone marrow stromal cells.
Wu C; Zhou Y; Chang J; Xiao Y
Acta Biomater; 2013 Nov; 9(11):9159-68. PubMed ID: 23811216
[TBL] [Abstract][Full Text] [Related]
12. Functional mesoporous bioactive glass nanospheres: synthesis, high loading efficiency, controllable delivery of doxorubicin and inhibitory effect on bone cancer cells.
Wu C; Fan W; Chang J
J Mater Chem B; 2013 Jun; 1(21):2710-2718. PubMed ID: 32260976
[TBL] [Abstract][Full Text] [Related]
13. The response of pre-osteoblasts and osteoclasts to gallium containing mesoporous bioactive glasses.
Gómez-Cerezo N; Verron E; Montouillout V; Fayon F; Lagadec P; Bouler JM; Bujoli B; Arcos D; Vallet-Regí M
Acta Biomater; 2018 Aug; 76():333-343. PubMed ID: 29966758
[TBL] [Abstract][Full Text] [Related]
14. Effects of a mesoporous bioactive glass on osteoblasts, osteoclasts and macrophages.
Gómez-Cerezo N; Casarrubios L; Morales I; Feito MJ; Vallet-Regí M; Arcos D; Portolés MT
J Colloid Interface Sci; 2018 Oct; 528():309-320. PubMed ID: 29859456
[TBL] [Abstract][Full Text] [Related]
15. Shikimic Acid Inhibits Osteoclastogenesis in Vivo and in Vitro by Blocking RANK/TRAF6 Association and Suppressing NF-κB and MAPK Signaling Pathways.
Chen X; Li X; Zhai X; Zhi X; Cao L; Qin L; Su J
Cell Physiol Biochem; 2018; 51(6):2858-2871. PubMed ID: 30562759
[TBL] [Abstract][Full Text] [Related]
16. Cell-free synthesis of connexin 43-integrated exosome-mimetic nanoparticles for siRNA delivery.
Lu M; Zhao X; Xing H; Liu H; Lang L; Yang T; Xun Z; Wang D; Ding P
Acta Biomater; 2019 Sep; 96():517-536. PubMed ID: 31284098
[TBL] [Abstract][Full Text] [Related]
17. Ameloblastin attenuates RANKL-mediated osteoclastogenesis by suppressing activation of nuclear factor of activated T-cell cytoplasmic 1 (NFATc1).
Chaweewannakorn W; Ariyoshi W; Okinaga T; Fujita Y; Maki K; Nishihara T
J Cell Physiol; 2019 Feb; 234(2):1745-1757. PubMed ID: 30105896
[TBL] [Abstract][Full Text] [Related]
18. A strategy using mesoporous polymer nanospheres as nanocarriers of Bcl-2 siRNA towards breast cancer therapy.
Wu X; Zheng Y; Yang D; Chen T; Feng B; Weng J; Wang J; Zhang K; Zhang X
J Mater Chem B; 2019 Jan; 7(3):477-487. PubMed ID: 32254735
[TBL] [Abstract][Full Text] [Related]
19. The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis.
Miyauchi Y; Ninomiya K; Miyamoto H; Sakamoto A; Iwasaki R; Hoshi H; Miyamoto K; Hao W; Yoshida S; Morioka H; Chiba K; Kato S; Tokuhisa T; Saitou M; Toyama Y; Suda T; Miyamoto T
J Exp Med; 2010 Apr; 207(4):751-62. PubMed ID: 20368579
[TBL] [Abstract][Full Text] [Related]
20. Osteoprotegerin expressed by osteoclasts: an autoregulator of osteoclastogenesis.
Kang JH; Ko HM; Moon JS; Yoo HI; Jung JY; Kim MS; Koh JT; Kim WJ; Kim SH
J Dent Res; 2014 Nov; 93(11):1116-23. PubMed ID: 25256714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
